Abstract
In this paper, we examine the hypothesis that 4-hydroxynonenal (HNE), a product of lipid peroxidation, is a key mediator of cell death resulting from beta-amyloid exposure. We revisit the effects of HNE on different neuronal cell types to determine which caspase or caspases are required for HNE-induced death, and to compare these results with the known caspase requirements in other death paradigms. We have previously shown that in a given neuronal cell type different death stimuli can evoke stimulus-specific apoptotic pathways. We now show that HNE treatment of neuronal cells induced dose-dependent death and caspase activity which were blocked by inhibition of caspases. Antisense down-regulation of caspases-3, -7 or -9 provided complete protection from HNE-induced death, as did down-regulation of the caspase regulators APAF-1 and DIABLO. Conversely, this work and our previous studies of three other death paradigms show that caspase-3 is not required for death induced by beta-amyloid, SOD1 down-regulation, or trophic factor deprivation. We also show that HNE accumulated in settings where death does not ensue. We conclude that HNE toxicity is mediated via a caspase-9-dependent pathway but that HNE accumulation need not induce cell death nor is it an obligate mediator of Abeta-induced cell death.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Aldehydes / metabolism*
-
Aldehydes / toxicity
-
Amyloid beta-Peptides / metabolism*
-
Amyloid beta-Peptides / toxicity
-
Animals
-
Animals, Newborn
-
Apoptosis / drug effects
-
Apoptosis / physiology*
-
Apoptosis Regulatory Proteins
-
Apoptotic Protease-Activating Factor 1
-
Carrier Proteins / drug effects
-
Carrier Proteins / metabolism
-
Caspase 3
-
Caspase 9
-
Caspase Inhibitors
-
Caspases / metabolism
-
Central Nervous System / metabolism*
-
Central Nervous System / physiopathology
-
Dose-Response Relationship, Drug
-
Down-Regulation / drug effects
-
Down-Regulation / physiology
-
Enzyme Inhibitors / pharmacology
-
Mice
-
Mitochondrial Proteins / drug effects
-
Mitochondrial Proteins / metabolism
-
Nerve Growth Factors / deficiency
-
Neurodegenerative Diseases / metabolism*
-
Neurodegenerative Diseases / physiopathology
-
Neurons / drug effects
-
Neurons / metabolism*
-
Neurons / pathology
-
PC12 Cells
-
Proteins / metabolism
-
Rats
-
Superoxide Dismutase / deficiency
-
Superoxide Dismutase-1
Substances
-
Aldehydes
-
Amyloid beta-Peptides
-
Apaf1 protein, mouse
-
Apaf1 protein, rat
-
Apoptosis Regulatory Proteins
-
Apoptotic Protease-Activating Factor 1
-
Carrier Proteins
-
Caspase Inhibitors
-
DIABLO protein, rat
-
Diablo protein, mouse
-
Enzyme Inhibitors
-
Mitochondrial Proteins
-
Nerve Growth Factors
-
Proteins
-
Sod1 protein, mouse
-
Sod1 protein, rat
-
Superoxide Dismutase
-
Superoxide Dismutase-1
-
Casp3 protein, mouse
-
Casp3 protein, rat
-
Casp9 protein, mouse
-
Casp9 protein, rat
-
Caspase 3
-
Caspase 9
-
Caspases
-
4-hydroxy-2-nonenal